Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.560
-0.100 (-2.73%)
At close: Mar 6, 2026, 4:00 PM EST
3.600
+0.040 (1.12%)
After-hours: Mar 6, 2026, 4:48 PM EST
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$371,851
Profits / Employee
-$159,248
Market Cap
265.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 172 |
| Coherus Oncology | 158 |
| Abeona Therapeutics | 136 |
| OmniAb | 114 |
| Enlivex | 71 |
| Cybin | 50 |
| ALX Oncology Holdings | 44 |
| Surrozen | 41 |
CLLS News
- 3 days ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 2 months ago - Monthly information on share capital and company voting rights - GlobeNewsWire
- 2 months ago - Cellectis (CLLS) Receives New 'Buy' Rating from Clear Street | CLLS Stock News - GuruFocus
- 2 months ago - Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This - Seeking Alpha
- 2 months ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 2 months ago - Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Benzinga
- 2 months ago - Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis - GlobeNewsWire
- 2 months ago - Cellectis (CLLS) Arbitration Outcome Adjusts License Agreement - GuruFocus